Back to Trades
Dagher Ibrahim B.
DirectorCIK 0002019599
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Dagher Ibrahim B., Director, has filed 1 SEC report (2026), all concentrated in BRAINSTORM CELL THERAPEUTICS INC. (BCLI), totaling $157.5K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| May 20 | BCLI BRAINSTORM CELL THERAPEUTICS INC. | Dagher Ibrahim B. | Director | Award | $157.5K |
1 filing